Pharmaceutical Dextropropoxyphene Napsylate Powder from Japan
Fine powder of dextropropoxyphene napsylate for compounding in pain relief formulations. Classified in HTS 2922.14.00.00 following chapter rules for salts of listed INN compounds in this amino-alcohol subheading.
Duty Rate — Japan → United States
27.5%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Secure end-user statements for non-human consumption if research-grade
• Package with stabilizers only if necessary for transport per note (f) to maintain classification
• Monitor FDA import alerts for opioid precursors